The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males | BeOne Medicines

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

Beigene Study ID

BGB-3111-112

ClinicalTrials.gov ID

NCT04470908

Study Overview

Sex: Male

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: Male

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan